SOD3 and inflammatory bowel disease: Taken together, our findings demonstrate that SOD3 protein or SOD3-MSCs might be promising therapeutics for the treatment of IBD through the downregulation of inflammatory responses, as well as the maintenance of epithelial junctional integrity.